Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC on OPPS outliers

This article was originally published in The Gray Sheet

Executive Summary

Hospital outlier policy should be disbanded, the Medicare Payment Advisory Commission formally recommends in its 1March report to Congress. Citing research showing that low-cost procedures with payment rates of $300 or less took the bulk of outlier payments in 2002, the commission contends the policy designed to provide additional payments for extremely costly cases is not being used as intended (2"The Gray Sheet" Jan. 19, 2004, p. 14)...

You may also be interested in...



Outlier Payment Qualification Standards Raised By CMS

CMS will adopt a fixed-dollar threshold of $1,175 for "outlier" payment qualification in 2005, raising the previous threshold amount by $550

MedPAC Votes To Oust Medicare Hospital Outpatient Outlier System

Congress should eliminate Medicare's outlier policy under the hospital OPPS and return the funds to the payment baseline, the MedPAC recommended Jan. 15 in Washington, D.C

Who’s Hired? Hikma Recruits New US Generics President

A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel